Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carnitine acyltransferases enable critical steps in lipid metabolism by shuttling fatty acids into mitochondria via reversible transfer between CoA and carnitine. Their unique structural features facilitate substrate binding/catalysis through conserved histidine residues within an active-site tunnel. Tight regulation ensures proper energy homeostasis; dysfunction leads to significant disease risk making them important drug targets.
Inhibition of carnitine palmitoyltransferase I (CPT-I)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carnitine Acyltransferase (CAT).